CZ ATC N06DX01 · updated 2 Nov 2026
Memantine shortage in Czechia
Is there a Memantine shortage in Czechia?
Yes. As of 2 Nov 2026, 17 Memantine products are reported short in Czechia, the first since 1 Oct 2024. The company estimate for the return is 20 Nov 2026 (latest 1 Sep 2028). Main reason: commercial decision or withdrawal.
Also short in Canada, Italy, Spain, Ireland, Austria, Belgium, Japan. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | MANTOMED 10MG 10MG TBL FLM 70 I | Medochemie Ltd., Limassol | 1 Oct 2024 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | MORYSA 20MG 20MG TBL FLM 30 | Neuraxpharm Bohemia s.r.o., Praha | 1 Jun 2025 | 28 Feb 2027 | Manufacturing problem Výrobní důvody |
| CZ | MANTOMED 10MG 10MG TBL FLM 60 I | Medochemie Ltd., Limassol | 12 Aug 2025 | 1 Sep 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | MANTOMED 20MG 20MG TBL FLM 60 I | Medochemie Ltd., Limassol | 3 Oct 2025 | 1 Sep 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | MANTOMED 10MG 10MG TBL FLM 70 II | Medochemie Ltd., Limassol | 30 Jan 2026 | 3 Jan 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | MANTOMED 20MG 20MG TBL FLM 70 II | Medochemie Ltd., Limassol | 30 Jan 2026 | 3 Jan 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | MORYSA 10MG 10MG TBL FLM 30 | Neuraxpharm Bohemia s.r.o., Praha | 17 May 2026 | 28 Feb 2027 | Manufacturing problem Výrobní důvody |
| CZ | MEMANTIN SANDOZ 10MG 10MG TBL FLM 30 | Sandoz s.r.o., Praha | 3 Aug 2026 | 20 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | NEMDATINE 20MG 20MG TBL FLM 28 | Teva | 18 Aug 2026 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | MEMANTIN SANDOZ 20MG 20MG TBL FLM 30 | Sandoz s.r.o., Praha | 21 Oct 2026 | 11 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | MEMANTIN MYLAN 10MG 10MG TBL FLM 56 | Mylan Pharmaceuticals Limited, Dublin | 25 Oct 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | MANTOMED 10MG 10MG TBL FLM 56 I | Medochemie Ltd., Limassol | 1 Nov 2026 | 1 Sep 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | MANTOMED 20MG 20MG TBL FLM 56 I | Medochemie Ltd., Limassol | 1 Nov 2026 | 1 Sep 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | MEMANTIN MYLAN 10MG 10MG TBL FLM 28 | Mylan Pharmaceuticals Limited, Dublin | 1 Nov 2026 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | NEMDATINE 10MG 10MG TBL FLM 56 anticipated | Teva | 9 Nov 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | MANTOMED 10MG 10MG TBL FLM 60 II anticipated | Medochemie Ltd., Limassol | 11 Dec 2026 | 1 Aug 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | MANTOMED 20MG 20MG TBL FLM 60 II anticipated | Medochemie Ltd., Limassol | 31 Dec 2026 | 1 Aug 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.